Dr. Ole Pless, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP ScreeningPort, shares his research on using human induced pluripotent stem cell (hiPSC) technology to better understand the blood-brain barrier for translational research and drug discovery in neurodegenerative diseases.
All information presented is for informational purposes only and is not intended for medical advice.
Expert interview: recapitulating the blood-brain barrier using in vitro hiPSC models in drug discovery